Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Angell

Showing results (41-50 of 45) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 45 results.
Human Reproduction (Oxford, England)|January 1, 1989
Glucose phosphate isomerase activity in mouse and human eggs and pre-embryosJ D West, J H Flockhart, R R Angell, et al.
British Journal of Pharmacology|March 22, 2005
GW274150 and GW273629 are potent and highly selective inhibitors of inducible nitric oxide synthase in vitro and in vivoWendy K Alderton, Anthony D R Angell, Caroline Craig, et al.
The Journal of Pharmacology and Experimental Therapeutics|January 6, 2011
GSK256066, an exceptionally high-affinity and selective inhibitor of phosphodiesterase 4 suitable for administration by inhalation: in vitro, kinetic, and in vivo characterizationCathy J Tralau-Stewart, Richard A Williamson, Anthony T Nials, et al.
Bioorganic & Medicinal Chemistry Letters|April 13, 2011
Heteroalicyclic carboxamidines as inhibitors of inducible nitric oxide synthase; the identification of (2R)-2-pyrrolidinecarboxamidine as a potent and selective haem-co-ordinating inhibitorRobert J Young, Wendy Alderton, Anthony D R Angell, et al.
Bioorganic & Medicinal Chemistry Letters|June 10, 2008
Pyrazolopyridines as a novel structural class of potent and selective PDE4 inhibitorsJ Nicole Hamblin, Tony D R Angell, Stuart P Ballantine, et al.
Pageof 5

Showing results (41-50 of 45) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 45 results.
Human Reproduction (Oxford, England)|January 1, 1989
Glucose phosphate isomerase activity in mouse and human eggs and pre-embryosJ D West, J H Flockhart, R R Angell, et al.
British Journal of Pharmacology|March 22, 2005
GW274150 and GW273629 are potent and highly selective inhibitors of inducible nitric oxide synthase in vitro and in vivoWendy K Alderton, Anthony D R Angell, Caroline Craig, et al.
The Journal of Pharmacology and Experimental Therapeutics|January 6, 2011
GSK256066, an exceptionally high-affinity and selective inhibitor of phosphodiesterase 4 suitable for administration by inhalation: in vitro, kinetic, and in vivo characterizationCathy J Tralau-Stewart, Richard A Williamson, Anthony T Nials, et al.
Bioorganic & Medicinal Chemistry Letters|April 13, 2011
Heteroalicyclic carboxamidines as inhibitors of inducible nitric oxide synthase; the identification of (2R)-2-pyrrolidinecarboxamidine as a potent and selective haem-co-ordinating inhibitorRobert J Young, Wendy Alderton, Anthony D R Angell, et al.
Bioorganic & Medicinal Chemistry Letters|June 10, 2008
Pyrazolopyridines as a novel structural class of potent and selective PDE4 inhibitorsJ Nicole Hamblin, Tony D R Angell, Stuart P Ballantine, et al.
Pageof 5